Core Viewpoint - The company has received approval from the National Medical Products Administration for the registration of aluminum magnesium carbonate chewable tablets, which enhances its product pipeline and supports sustainable development [1][4]. Drug Basic Information - Drug Name: Aluminum Magnesium Carbonate Chewable Tablets - Dosage Form: Tablet - Specification: 0.5g - Registration Classification: Class 4 Chemical Drug - Approval Number: Guo Yao Zhun Zi H20263134 - License Holder: Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. - Approval Conclusion: The drug meets registration requirements and is classified as a Class A over-the-counter medication [1]. Drug Efficacy and Market Potential - Aluminum magnesium carbonate chewable tablets are a first-line medication for the digestive system, providing antacid, bile acid neutralization, and mucosal protection, suitable for treating various gastric diseases including acute and chronic gastritis, gastric and duodenal ulcers, and gastroesophageal reflux disease [2]. - The product is projected to have a total sales volume of 990 million yuan in the domestic medical and retail markets by 2024 [2]. R&D Investment - As of the announcement date, the cumulative R&D investment in aluminum magnesium carbonate chewable tablets by Qianjin Xiangjiang Pharmaceutical is 1.0047 million yuan [3]. Impact on the Company - The approval of aluminum magnesium carbonate chewable tablets is seen as a significant step in enhancing the company's product offerings, contributing positively to its sustainable growth [4].

Core Viewpoint - The company, Dalian Shengya Tourism Holdings Co., Ltd., is forecasting a turnaround in its financial performance for the year 2025, expecting a net profit attributable to shareholders of between 22 million and 33 million yuan, compared to a loss in the previous year [2][4]. Group 1: Performance Forecast - The performance forecast period is from January 1, 2025, to December 31, 2025 [3]. - The expected net profit attributable to shareholders is projected to be between 22 million and 33 million yuan, indicating a return to profitability compared to a net loss of approximately 70.18 million yuan in the previous year [2][4][6]. - The forecasted net profit after deducting non-recurring gains and losses is estimated to be between 47.8 million and 71.7 million yuan [2][4]. Group 2: Previous Year’s Performance - In the previous year, the total profit was a loss of 41.14 million yuan, with a net loss attributable to shareholders of 70.18 million yuan [6]. - The net profit after deducting non-recurring gains and losses was approximately 2.08 million yuan [6]. Group 3: Reasons for Performance Change - The anticipated turnaround in 2025 is attributed to a decrease in litigation compensation amounts, lower costs related to litigation cases, and reduced obligations for project investment shortfalls compared to the previous period [8].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600062 证券简称：华润双鹤 公告编号：临2026－007 华润双鹤药业股份有限公司 公司将按照有关法律法规、批复要求及公司股东会授权办理本次公司债券发行的相关事宜，并及时履行 信息披露义务。 特此公告。 华润双鹤药业股份有限公司 董事会 2026年1月27日 关于向专业投资者公开发行公司债券获得中国证监会批复的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 华润双鹤药业股份有限公司(以下简称"公司")于近日收到中国证券监督管理委员会(以下简称"中国证监 会")出具的《关于同意华润双鹤药业股份有限公司向专业投资者公开发行公司债券注册的批复》(证监 许可[2026]118号)。据此批复，中国证监会同意公司向专业投资者公开发行面值总额不超过30亿元公司 债券的注册申请。该批复自同意注册之日起24个月内有效，公司在注册有效期内可以分期发行公司债 券。 ...

Group 1 - The company held its 9th meeting of the 10th Board of Directors on January 26, 2026, with all 9 directors present, and the meeting was conducted in compliance with relevant laws and regulations [5][3][4] - The company plans to undertake 87 capital expenditure projects in 2026, with an estimated total amount of 186.61 million yuan, including various construction and research projects [6] - The company approved a futures hedging operation plan for 2026, with a maximum opening guarantee amount of 231.5 million yuan, aimed at reducing product price volatility risks [10][37] Group 2 - The company intends to use up to 1 billion yuan of temporarily idle self-owned funds for cash management, with a limit of 300 million yuan for low-risk financial products [25][26] - The cash management plan was approved by the Board of Directors and does not require shareholder approval, ensuring that it will not affect the company's normal operational funds [29][11] - The company will conduct futures hedging transactions primarily in domestic futures exchanges to manage risks associated with price fluctuations of aluminum and alumina [37][38]

Core Viewpoint - Qingdao Double Star Co., Ltd. plans to issue shares and pay cash to acquire assets, ultimately achieving a 45% stake in Kumho Tire Co., Inc. and gaining control over it [1] Group 1: Transaction Details - The company received an inquiry letter from the Shenzhen Stock Exchange regarding the issuance of shares and cash for asset acquisition on November 22, 2024 [2] - On December 20, 2024, the company disclosed its response to the inquiry letter and related documents [2] - The company updated financial data and provided supplementary responses to the inquiry letter on April 25, 2025 [2] - An asset appraisal was conducted by Zhongtonghua Asset Appraisal Co., Ltd. with a new base date of June 30, 2025, to ensure the asset value had not deteriorated [2] - The company updated financial data and disclosed revised documents on September 20, 2025 [2] - Following a fire incident at Kumho Tire's Gwangju plant, the company updated its disclosures on December 11, 2025 [2] - The fourth extraordinary shareholders' meeting was held on December 26, 2025, to re-examine the transaction proposals [2] - The company continued to work on the transaction, adhering to necessary approval and review procedures [3] Group 2: Regulatory Compliance - The transaction requires approval, registration, or consent from relevant regulatory authorities, with uncertainties regarding the timing of such approvals [3] - The company commits to fulfilling information disclosure obligations in accordance with legal regulations [3]

根据《公司法》《公司章程》及相关法律法规的规定，冯茂慧先生的辞职未导致公司董事会成员低于法 定人数，其辞职不会影响公司董事会的正常运行，辞职报告自送达公司董事会之日起生效。公司将按照 相关法律法规和《公司章程》的规定尽快完成董事的补选工作。 恒天海龙股份有限公司 董事会 恒天海龙股份有限公司（以下简称"公司"）董事会于近日收到公司董事冯茂慧先生的书面辞职报告。冯 茂慧先生因工作变动原因申请辞去公司第十三届董事会董事职务、审计委员会委员及薪酬与考核委员会 委员职务。冯茂慧先生前述职务原定任期至公司第十三届董事会届满之日止。冯茂慧先生辞职后，不再 在公司及控股子公司担任其他职务。 2026年1月26日 截至本公告日，冯茂慧先生未持有公司股票，亦不存在应当履行而未履行的承诺事项。 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性陈述或者重大遗 漏。 公司董事会对冯茂慧先生在任职期间为公司所作出的贡献表示衷心的感谢。特此公告。 ...

Core Viewpoint - The company has authorized its management to dispose of financial assets based on market conditions, with the authorization period extending until the next annual shareholders' meeting in 2025 [1]. Group 1: Transaction Progress - From June 24, 2025, to January 26, 2026, the company sold financial assets including CITIC shares and Boqian New Materials, with a cumulative transaction amount of 430,908.48 million yuan, which accounts for 10.46% of the company's audited net assets as of the end of 2024 [2]. Group 2: Impact on the Company - The company has been implementing the new financial instrument standards since January 1, 2019. The financial assets such as CITIC shares are classified as "measured at fair value with changes recognized in other comprehensive income," meaning their value fluctuations and disposals do not affect the current profit and loss, with only dividend income impacting current investment income [3].

证券代码：000723 证券简称：美锦能源 公告编号：2026-008 债券代码：127061 债券简称：美锦转债 山西美锦能源股份有限公司关于 第一大股东部分股份解除质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 登录新浪财经APP 搜索【信披】查看更多考评等级 1、本次股份解除质押基本情况 ■ 2、股东股份累计质押基本情况 截至2026年1月23日，上述股东及其一致行动人所持质押股份情况如下： ■ 二、备查文件 特别风险提示： 山西美锦能源股份有限公司（以下简称"公司"）第一大股东美锦能源集团有限公司（以下简称"美锦集 团"）质押股份数量占其所持公司股份数量比例超过80%，请投资者注意相关风险。 一、股东股份解除质押基本情况 公司近日接到美锦集团通知，获悉美锦集团所持有公司的部分股份解除质押，具体事项如下： 1、股份解除质押登记证明； 2、深交所要求的其他文件。 特此公告。 山西美锦能源股份有限公司董事会 2026年1月26日 ...

(一)股东会召开的时间：2026年1月26日 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 本次会议是否有否决议案：无 一、会议召开和出席情况 (二)股东会召开的地点：广州市番禺区汉溪大道东386号广晟万博城A塔写字楼37楼会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： ■ (四)表决方式是否符合《公司法》及《公司章程》的规定，会议主持情况等。 本次会议由董事长杨杰先生主持。会议的召集、召开和表决方式符合《公司法》《公司章程》及《股东 会议事规则》的相关规定。 (五)公司董事和董事会秘书的列席情况 1、公司在任董事8人，列席5人，董事范安胜先生、钟瑞林先生、刘子龙先生因工作原因无法出席会 议。 2、董事会秘书柯昌波先生、其他高级管理人员及公司聘请的见证律师出席了本次会议。 二、议案审议情况 ■ (三)关于议案表决的有关情况说明 (一)累积投票议案表决情况 1、关于选举董事的议案 ■ (二)涉及重大事项，5%以下股东的表决情况 上述议案已经公司第九届董事会2026年第一次会议审 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 华能国际电力股份有限公司（"公司"或"华能国际"）股东会已于2025年9月23日审议通过了关于修订 《公司章程》的相关议案。根据修订后的《公司章程》，公司董事会由18名董事组成，其中包括1名职 工代表董事。职工代表董事通过公司职工代表大会、职工大会或者其他形式民主选举产生，无需提交公 司股东会审议。 公司于近日召开第二届职工代表大会第六次会议，选举王钰先生为公司第十一届董事会职工代表董事， 任期自2026年1月26日起至公司第十一届董事会任期届满之日止。王钰先生简历请见本公告附件。 董事会 2026年1月27日 王钰，1972年7月出生。现任华能国际办公室（董事会办公室）主任、华能（浙江）能源开发有限公司 董事、华能石岛湾核电开发有限公司董事。曾任华能国际财务部资金结算中心副主任、主任，资金二处 处长，财务与预算部资金处处长，纪律检查与审计部副主任，法律合规部主任，职工代表监事。毕业于 中国海洋大学项目管理专业，工程硕士。 除上述简历披露的任职关系外，王钰先生与华能国际的董事、高 ...